Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in V600D/EBRAF mutant melanoma depends on JNK and TNF-α signaling
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in V600D/EBRAF mutant melanoma depends on JNK and TNF-α signaling
Authors
Keywords
-
Journal
ONCOGENE
Volume 33, Issue 13, Pages 1700-1712
Publisher
Springer Nature
Online
2013-04-29
DOI
10.1038/onc.2013.112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncolytic Vaccinia virus and radiotherapy in head and neck cancer
- (2012) D. Mansfield et al. ORAL ONCOLOGY
- Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68
- (2011) Maria Libera Ascierto et al. BMC CANCER
- Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
- (2011) Lucy Heinemann et al. BMC CANCER
- The Evolving Role of Radiation Therapy in the Management of Malignant Melanoma
- (2011) Niloufer Khan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers
- (2010) K. J. Harrington et al. CLINICAL CANCER RESEARCH
- REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer
- (2010) C. Comins et al. CLINICAL CANCER RESEARCH
- Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma
- (2009) H. S. Pandha et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases
- (2009) R. K. Amaravadi et al. CLINICAL CANCER RESEARCH
- Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
- (2009) Robert G. Maki et al. JOURNAL OF CLINICAL ONCOLOGY
- Activation of the PI3K/Akt Pathway Early during Vaccinia and Cowpox Virus Infections Is Required for both Host Survival and Viral Replication
- (2009) J. A. P. Soares et al. JOURNAL OF VIROLOGY
- Oncolytic vaccinia therapy of squamous cell carcinoma
- (2009) Zhenkun Yu et al. Molecular Cancer
- Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68
- (2009) Y. A. Yu et al. MOLECULAR CANCER THERAPEUTICS
- Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent
- (2008) I Gentschev et al. CANCER GENE THERAPY
- Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy
- (2008) K. Twigger et al. CLINICAL CANCER RESEARCH
- Novel Oncolytic Agent GLV-1h68 Is Effective Against Malignant Pleural Mesothelioma
- (2008) Kaitlyn J. Kelly et al. HUMAN GENE THERAPY
- Oncolytic Vaccinia Virotherapy of Anaplastic Thyroid Cancerin Vivo
- (2008) Shu-Fu Lin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
- (2008) J. Tsai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started